EMBC (Embecta) Beginning Cash Position: $204 Mil (As of Mar. 2026)


EMBC Embecta Corp EMBC
53 GF Score
Price $3.25
GF Value $12.67
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Embecta Beginning Cash Position?

Embecta EMBC +1.89% 53 Beginning Cash Position is $204 Mil as of Mar. 2026. GuruFocus rates EMBC with a GF Score™ of 53/100 and a GF Value™ of $12.67 (Possible Value Trap). The stock has 6 warning signs investors should review.

Embecta's Beginning Cash Position for the quarter that ended in Mar. 2026 was $204 Mil.

Embecta's quarterly Beginning Cash Position declined from Sep. 2025 ($234 Mil) to Dec. 2025 ($229 Mil) and declined from Dec. 2025 ($229 Mil) to Mar. 2026 ($204 Mil).

Embecta's annual Beginning Cash Position declined from Sep. 2023 ($331 Mil) to Sep. 2024 ($327 Mil) and declined from Sep. 2024 ($327 Mil) to Sep. 2025 ($274 Mil).

Embecta Beginning Cash Position Related Terms

Embecta Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Embecta's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embecta Beginning Cash Position Chart

Embecta Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Beginning Cash Position
Get a 7-Day Free Trial 0.00 0.00 330.90 326.50 274.20

Embecta Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 216.70 212.30 233.60 228.60 204.40
EMBC
53GF Score
Embecta Corp EMBC
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Embecta Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $204 Mil mean?
Embecta (EMBC) has a Beginning Cash Position of $204 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Embecta and its competitors.
Is Embecta's Beginning Cash Position too high?
Embecta's current Beginning Cash Position is $204 Mil. Overall, Embecta has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Embecta's Beginning Cash Position compare to KRMD and SMTI?
Embecta's Beginning Cash Position of $204 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Embecta and its competitors. Embecta's current Beginning Cash Position is $204 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embecta stock overvalued right now?
Based on GuruFocus' analysis, Embecta (EMBC) is currently considered Possible Value Trap. The stock's GF Value™ is $12.67, compared to a current price of $3.25 — trading 74.3% below its estimated fair value. The current Beginning Cash Position is $204 Mil. Embecta's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Embecta (EMBC), the current Beginning Cash Position is $204 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Embecta (EMBC) Overvalued in 2026?

Based on GuruFocus' analysis, Embecta stock appears to be undervalued. The current stock price of $3.25 is trading 74.3% below its estimated GF Value™ of $12.67. GuruFocus considers Embecta to be Possible Value Trap.

Key valuation signals for EMBC:

  • Beginning Cash Position: $204 Mil
  • GF Value™: $12.67 vs. price of $3.25 (74.3% below fair value)
  • GF Score™: 53/100 with 6 warning signs

No single metric tells the full story. See the EMBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Embecta Business Description

Other Exchanges JX7:Germany
Address 300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
53GF Score

Get the complete analysis for EMBC

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.25
Price
$12.67
GF Value